X0306 5 2020-12-31 0 0 1 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001684087 Young Caroline 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203 1 0 0 0 Common Stock 2020-10-01 4 L 0 15 3.29 A 10083 D Common Stock 2020-10-02 4 L 0 15 3.33 A 10098 D Common Stock 2020-10-05 4 L 0 15 3.35 A 10113 D Common Stock 2020-10-06 4 L 0 15 3.35 A 10128 D Common Stock 2020-10-07 4 L 0 15 3.24 A 10143 D Common Stock 2020-10-08 4 L 0 15 3.24 A 10158 D Common Stock 2020-10-09 4 L 0 15 3.25 A 10173 D Common Stock 2020-10-12 4 L 0 15 3.23 A 10188 D Common Stock 2020-10-13 4 L 0 15 3.21 A 10203 D Common Stock 2020-10-14 4 L 0 15 3.14 A 10218 D Common Stock 2020-10-15 4 L 0 15 3.07 A 10233 D Common Stock 2020-10-16 4 L 0 15 3.07 A 10248 D Common Stock 2020-10-19 4 L 0 15 3.03 A 10263 D Common Stock 2020-10-20 4 L 0 15 3.04 A 10278 D Common Stock 2020-10-21 4 L 0 15 3.04 A 10293 D Common Stock 2020-10-22 4 L 0 15 3.08 A 10308 D Common Stock 2020-10-23 4 L 0 15 3.04 A 10323 D Common Stock 2020-10-26 4 L 0 15 3.02 A 10338 D Common Stock 2020-10-27 4 L 0 15 3.06 A 10353 D Common Stock 2020-10-28 4 L 0 15 2.97 A 10368 D Common Stock 2020-10-29 4 L 0 15 3.02 A 10383 D Common Stock 2020-10-30 4 L 0 15 2.99 A 10398 D Common Stock 2020-11-02 4 L 0 15 2.97 A 10413 D Common Stock 2020-11-03 4 L 0 15 2.99 A 10428 D Common Stock 2020-11-04 4 L 0 15 3.01 A 10443 D Common Stock 2020-11-05 4 L 0 15 2.98 A 10458 D Common Stock 2020-11-06 4 L 0 15 2.99 A 10473 D Common Stock 2020-11-09 4 L 0 15 3.06 A 10488 D Common Stock 2020-11-10 4 L 0 15 3.09 A 10503 D Common Stock 2020-11-11 4 L 0 15 3.12 A 10518 D The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Filing 5 of 6 Caroline Young by /s/ Michael Bonner as attorney-in-fact 2021-02-05